Acute Leukemia
202
49
64
74
Key Insights
Highlights
Success Rate
86% trial completion
Published Results
28 trials with published results (14%)
Research Maturity
74 completed trials (37% of total)
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 62/100
5.9%
12 terminated out of 202 trials
86.0%
-0.5% vs benchmark
5%
10 trials in Phase 3/4
38%
28 of 74 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 74 completed trials
Clinical Trials (202)
Strength Training Exercise in Pediatric Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma (STEP-ALL)
A Phase 1/2 Study of Bleximenib in Participants With Acute Leukemia (cAMeLot-1)
Brain MRF in Children, Adolescents and Young Adults With Acute Leukemia
A High Intensity Electronic Health Intervention for the Reduction of Learning Disparities in Childhood Cancer Survivors
Precision-T: A Study of Orca-T in Recipients Undergoing Allogeneic Transplantation for Hematologic Malignancies
A Trial of Fosfomycin vs Ciprofloxacin for Febrile Neutropenia (FOVOCIP)
Donor Stem Cell Transplant With Treosulfan, Fludarabine, and Total-Body Irradiation for the Treatment of Hematological Malignancies
Tocilizumab for the Prevention of Graft Versus Host Disease After Cord Blood Transplantation
Tools for Reducing Inequity in Acute Leukemia (TRIAL): Beta Testing
Naive T Cell Depletion for Preventing Chronic Graft-versus-Host Disease in Children and Young Adults With Blood Cancers Undergoing Donor Stem Cell Transplant
Study of QUAIL-100 in Pediatric and Young Adult Participants With High-Risk Hematologic Malignancies Who Have Received a Hematopoietic Stem Cell Transplantation
Reduced Intensity Allogeneic HCT in Advanced Hematologic Malignancies w/T-Cell Depleted Graft
Thiotepa-based Conditioning Regimen With De-escalated Post-graft Cyclophosphamide for Allogeneic Stem Cell Transplantation in Hematologic Malignancies
A Real-world Study on the Efficacy and Safety of Menin Inhibitors as Maintenance After Allo-HSCT
Benefits of Formalized Care Support Program Following Acute Leukemia Diagnosis
High-Intensity Parent Intervention Program in Improving Learning and School Functioning in Latino Children With Acute Leukemia or Lymphoblastic Lymphoma
Familial Investigations of Childhood Cancer Predisposition
Action of the Vidaza on the Atrial Fibrillation
Predictive Clinical and Biological Parameters in Acute Leukemia, Myelodysplastic Syndromes and Myeloproliferative Disorders-HEMATO-BIO-IPC-2013-015
Study Assessing RLT Using [177Lu]Lu-PentixaTher for Relapsed/Refractory CXCR4+ Acute Leukemia.